R D Barr|P S Sarin|S M Perry - JoVE Visualize

Showing results (131-140 of 209) with videos related to

Pageof 21

Sort By:

Archives of Disease in Childhood|September 1, 1982

Valproic acid and immune thrombocytopeniaR D Barr, S A Copeland, M L Stockwell, et al.

Vaccine|September 6, 2001

Induction of cross clade reactive specific antibodies in mice by conjugates of HGP-30 (peptide analog of HIV-1(SF2) p17) and peptide segments of human beta-2-microglobulin or MHC II beta chainD H Zimmerman, J P Lloyd, D Heisey, et al.

Science (New York, N.Y.)|February 18, 1983

Isolation and transmission of human retrovirus (human t-cell leukemia virus)M Popovic, P S Sarin, M Robert-Gurroff, et al.

Biochemical and Biophysical Research Communications|August 31, 1990

Lipid conjugates of antiretroviral agents. I. Azidothymidine-monophosphate-diglyceride: anti-HIV activity, physical properties, and interaction with plasma proteinsJ M Steim, C Camaioni Neto, P S Sarin, et al.

Proceedings of the National Academy of Sciences of the United States of America|September 1, 1990

HGP-30, a synthetic analogue of human immunodeficiency virus (HIV) p17, is a target for cytotoxic lymphocytes in HIV-infected individualsA Achour, O Picard, D Zagury, et al.

The Journal of Clinical Investigation|August 1, 1986

Production of 1,25-dihydroxyvitamin D3 by human T cell lymphotrophic virus-I-transformed lymphocytesD A Fetchick, D R Bertolini, P S Sarin, et al.

International Journal of Oncology|April 18, 1998

Cardiac autonomic dysfunction in survivors of acute lymphoblastic leukemia in childhoodM V Kamath, J Halton, A Harvey, et al.

British Journal of Haematology|July 1, 1981

Transient Donath-Landsteiner haemolytic anaemiaB Wolach, N Heddle, R D Barr, et al.

European Journal of Cancer (Oxford, England : 1990)|February 5, 2005

Use of paediatric versus adult oncology treatment centres by adolescents 15-19 years old: the Canadian Childhood Cancer Surveillance and Control ProgramJ Klein-Geltink, A K Shaw, H I Morrison, et al.

British Journal of Haematology|August 1, 1987

Relationship between platelet aggregating factor and von Willebrand factor in thrombotic thrombocytopenic purpuraW G Murphy, J C Moore, R D Barr, et al.

Pageof 21

Showing results (131-140 of 209) with videos related to

Sort By:

Pageof 21

Archives of Disease in Childhood|September 1, 1982

Valproic acid and immune thrombocytopeniaR D Barr, S A Copeland, M L Stockwell, et al.

Vaccine|September 6, 2001

Induction of cross clade reactive specific antibodies in mice by conjugates of HGP-30 (peptide analog of HIV-1(SF2) p17) and peptide segments of human beta-2-microglobulin or MHC II beta chainD H Zimmerman, J P Lloyd, D Heisey, et al.

Science (New York, N.Y.)|February 18, 1983

Isolation and transmission of human retrovirus (human t-cell leukemia virus)M Popovic, P S Sarin, M Robert-Gurroff, et al.

Biochemical and Biophysical Research Communications|August 31, 1990

Lipid conjugates of antiretroviral agents. I. Azidothymidine-monophosphate-diglyceride: anti-HIV activity, physical properties, and interaction with plasma proteinsJ M Steim, C Camaioni Neto, P S Sarin, et al.

Proceedings of the National Academy of Sciences of the United States of America|September 1, 1990

HGP-30, a synthetic analogue of human immunodeficiency virus (HIV) p17, is a target for cytotoxic lymphocytes in HIV-infected individualsA Achour, O Picard, D Zagury, et al.

The Journal of Clinical Investigation|August 1, 1986

Production of 1,25-dihydroxyvitamin D3 by human T cell lymphotrophic virus-I-transformed lymphocytesD A Fetchick, D R Bertolini, P S Sarin, et al.

International Journal of Oncology|April 18, 1998

Cardiac autonomic dysfunction in survivors of acute lymphoblastic leukemia in childhoodM V Kamath, J Halton, A Harvey, et al.

British Journal of Haematology|July 1, 1981

Transient Donath-Landsteiner haemolytic anaemiaB Wolach, N Heddle, R D Barr, et al.

European Journal of Cancer (Oxford, England : 1990)|February 5, 2005

Use of paediatric versus adult oncology treatment centres by adolescents 15-19 years old: the Canadian Childhood Cancer Surveillance and Control ProgramJ Klein-Geltink, A K Shaw, H I Morrison, et al.

British Journal of Haematology|August 1, 1987

Relationship between platelet aggregating factor and von Willebrand factor in thrombotic thrombocytopenic purpuraW G Murphy, J C Moore, R D Barr, et al.

Pageof 21